Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Abstract

Treating multiple myeloma with high-level dose chemotherapy supported by transplanted autologous stem cells is still the primary and appropriate therapeutic strategy in affected patients. Today, although the responses have improved considerably, especially during the treatment with the induction of the combination of immunomodulatory medication and proteasome blockers, no treatment approach has taken autologous stem cell transplantation into the background. In this review, we will share the recent place of autologous stem cell transplantation in myeloma will be discussed from pretransplant treatment to posttransplant. © 2023 Ondokuz Mayis Universitesi. All rights reserved.